362 related articles for article (PubMed ID: 15071036)
21. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
[TBL] [Abstract][Full Text] [Related]
22. Atypical presentation of post-kala-azar dermal leishmaniasis.
Islam QT; Basher A
Lancet Infect Dis; 2017 Nov; 17(11):1218. PubMed ID: 29115271
[No Abstract] [Full Text] [Related]
23. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
[TBL] [Abstract][Full Text] [Related]
24. Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern.
Mishra J; Madhubala R; Singh S
Parasitol Res; 2013 Mar; 112(3):1001-9. PubMed ID: 23242321
[TBL] [Abstract][Full Text] [Related]
25. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
[TBL] [Abstract][Full Text] [Related]
26. Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization.
Mebrahtu YB; Lawyer PG; Hendricks LD; Muigai R; Oster CN; Perkins PV; Koech DK; Pamba H; Roberts CR
Am J Trop Med Hyg; 1991 Sep; 45(3):290-6. PubMed ID: 1928563
[TBL] [Abstract][Full Text] [Related]
27. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
[TBL] [Abstract][Full Text] [Related]
29. Identification of Leishmania donovani isolates from different kala-azar foci in China by kDNA hybridization.
Hu X; Lu H; Luo P; Wang Z; Hu X; Yi T
Chin Med Sci J; 1992 Jun; 7(2):63-6. PubMed ID: 1450394
[TBL] [Abstract][Full Text] [Related]
30. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.
Alam MZ; Kuhls K; Schweynoch C; Sundar S; Rijal S; Shamsuzzaman AK; Raju BV; Salotra P; Dujardin JC; Schönian G
Infect Genet Evol; 2009 Jan; 9(1):24-31. PubMed ID: 18957333
[TBL] [Abstract][Full Text] [Related]
31. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
[TBL] [Abstract][Full Text] [Related]
32. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
[TBL] [Abstract][Full Text] [Related]
33. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
Khanra S; Sarraf NR; Das S; Das AK; Roy S; Manna M
Acta Trop; 2016 Dec; 164():177-184. PubMed ID: 27629023
[TBL] [Abstract][Full Text] [Related]
34. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient.
Stark D; Pett S; Marriott D; Harkness J
J Clin Microbiol; 2006 Mar; 44(3):1178-80. PubMed ID: 16517925
[TBL] [Abstract][Full Text] [Related]
35. Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India.
Srivastava P; Prajapati VK; Vanaerschot M; Van der Auwera G; Dujardin JC; Sundar S
Infect Genet Evol; 2010 Oct; 10(7):1145-50. PubMed ID: 20633704
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh.
el-Masum MA; Evans DA
Trans R Soc Trop Med Hyg; 1995; 89(3):331-2. PubMed ID: 7660453
[No Abstract] [Full Text] [Related]
37. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
38. RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.
Khanra S; Datta S; Mondal D; Saha P; Bandopadhyay SK; Roy S; Manna M
Acta Trop; 2012 Dec; 124(3):229-34. PubMed ID: 22960646
[TBL] [Abstract][Full Text] [Related]
39. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
Ramesh V
Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
[No Abstract] [Full Text] [Related]
40. Hypopigmented post-kala-azar dermal leishmaniasis.
Ramesh V; Ramam M; Singh R; Salotra P
Int J Dermatol; 2008 Apr; 47(4):414-6. PubMed ID: 18377613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
